A Clinical Study of SHR-3079 in B-cell Non-Hodgkin Lymphoma

NCT07661537 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

B-cell Non-Hodgkin Lymphoma

Interventions

DRUG: SHR-3079 Injection

Sponsor

Suzhou Suncadia Biopharmaceuticals Co., Ltd.